Coordinate Expression of Cytokines and Chemokines by NK Cells during Murine Cytomegalovirus Infection
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Cytokines and chemokines activate and direct effector cells during infection. We previously identified a functional group of five cytokines and chemokines, namely, IFN-γ, activation-induced T cell-derived and chemokine-related cytokine/lymphotactin, macrophage-inflammatory protein 1α, macrophage-inflammatory protein 1β, and RANTES, coexpressed in individual activated NK cells, CD8+ T cells, and CD4+ Th1 cells in vitro and during in vivo infections. However, the stimuli during infection were not known. In murine CMV (MCMV) infection, the DAP12/KARAP-associated Ly49H NK cell activation receptor is crucial for resistance through recognition of MCMV-encoded m157 but NK cells also undergo in vivo nonspecific responses to uncharacterized stimuli. In this study, we show that Ly49H ligation by m157 resulted in a coordinated release of all five cytokines/chemokines from Ly49H+ NK cells. Whereas other cytokines also triggered the release of these cytokines/chemokines, stimulation was not confined to the Ly49H+ population. At the single-cell level, the production of the five mediators showed strong positive correlation with each other. Interestingly, NK cells were a major source of these five cytokines/chemokines in vitro and in vivo, whereas infected macrophages produced only limited amounts of macrophage-inflammatory protein 1α, macrophage-inflammatory protein1β, and RANTES. These findings suggest that both virus-specific and nonspecific NK cells play crucial roles in activating and directing other inflammatory cells during MCMV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Cited by
Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 904
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
“Even in the same type of cancer, NK cells are highly heterogeneous, characterized by the abundance of surface receptors and the complexity of tumor intrinsic signaling pathways [95, 110].”
BackgroundNK cell development, homeostasis and function: parallels with CD8+ T cells
Sun, J. C., & Lanier, L. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3044 · Cited by 700
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
“A second, often underrated effector mechanism of NK cells is their capacity to secrete a variety of cytokines and chemokines, including interferon-g (IFN-g), TNF, GM-CSF (granulocyte-macrophage colony stimulating factor), MIP-1a (macrophage inflammatory protein-1a) and RANTES (regulated upon activation, normal T cell…”
BackgroundNatural killer cells as an initial defense against pathogens
Lodoen, M. B., & Lanier, L. L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.002 · Cited by 472
Relationship between CD107a expression and cytotoxic activity
Aktas, E., Kucuksezer, U. C., Bilgic, S., Erten, G., & Deniz, G. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2008.08.007 · Cited by 465
Dorner, B. G., Dorner, M. B., Zhou, X., Opitz, C., Mora, A., Güttler, S., Hutloff, A., Mages, H. W., Ranke, K., Schaefer, M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.027 · Cited by 456
Self-citationBozza, F. A., Cruz, O. G., Zagne, S. M., Azeredo, E. L., Nogueira, R. M., Assis, E. F., Bozza, P. T., & Kubelka, C. F. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-86 · Cited by 367
Liu, Z.-X., Govindarajan, S., & Kaplowitz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.053 · Cited by 328
Natural killer cells in human health and disease
Orange, J. S., & Ballas, Z. K. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.011 · Cited by 318
Lei, Y., Ripen, A. M., Ishimaru, N., Ohigashi, I., Nagasawa, T., Jeker, L. T., Bösl, M. R., Holländer, G. A., Hayashi, Y., de Waal Malefyt, R., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102327 · Cited by 308
Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G. M., Marcenaro, S., Dondero, A., Lazzeri, E., Lasagni, L., Martini, S., Rivera, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2696 · Cited by 268
Yu, J., Mao, H. C., Wei, M., Hughes, T., Zhang, J., Park, I.-K., Liu, S., McClory, S., Marcucci, G., Trotta, R., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215491 · Cited by 235
Vitale, M., Chiesa, M. D., Carlomagno, S., Romagnani, C., Thiel, A., Moretta, L., & Moretta, A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425100 · Cited by 197
Heger, L., Hatscher, L., Liang, C., Lehmann, C. H. K., Amon, L., Lühr, J. J., Kaszubowski, T., Nzirorera, R., Schaft, N., Dörrie, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300343120 · Cited by 54
Gui, Q., Wang, A., Zhao, X., Huang, S., Tan, Z., Xiao, C., & Yang, Y. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0670-z · Cited by 49
Metadata
- Authors
- Dorner, B. G., Smith, H. R. C., French, A. R., Kim, S., Poursine-Laurent, J., Beckman, D. L., Pingel, J. T., Kroczek, R. A., & Yokoyama, W. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 172
- Issue
- 5
- Pages
- 3119-3131
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1495950501
- Cited by
- 143
- References
- 2
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.